发明名称 Separación de proteínas plasmáticas
摘要 Separating fibrinogen (I), factor XIII (II) and biological glue (III) from a solubilized plasma fraction (A), based on (I) and (II), and preparing lyophilized concentrates of these proteins, is new. Separating fibrinogen (I), factor XIII (II) and biological glue (III) from a solubilized plasma fraction (A), based on (I) and (II), and preparing lyophilized concentrates of these proteins comprises: (A) chromatographic purification by (i) loading a weakly basic anion exchanger, previously equilibrated with a basic buffer of predetermined ionic strength, with (A) such that (III) is retained and (ii) eluting (III) by increasing the ionic strength of the buffer; (B) separation of (II) from (I) by adding to some of the eluted (III) an agent (IV) that precipitates (II), then recovery of the remaining solution from the supernatant of purified (II); and (C) diafiltration of the solutions of (I), (III) and redissolved (II), followed by lyophilization of the solution. An independent claim is included for lyophilized concentrates of (I), (II) and (III), prepared by the new method. - ACTIVITY : Hemostatic; Anticoagulant; Thrombolytic; Vulnerary. No biological data given. - MECHANISM OF ACTION : Fibrinogen is the precursor of fibrin clots.
申请公布号 ES2491215(T3) 申请公布日期 2014.09.05
申请号 ES20060013497T 申请日期 2006.06.29
申请人 LABORATOIRE FRANSAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES 发明人 NOGRE, MICHEL;PORTE, PIERRE;TELLIER, MICHEL
分类号 C07K14/745;A61P7/04;C07K1/22;C07K14/75;C07K14/78;C12N9/10 主分类号 C07K14/745
代理机构 代理人
主权项
地址